Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1622.31
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 23-Jul-2026
NAV [Rs.]
: 26.3666
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.31 | 2.78 | 11.82 | 18.52 | 14.98 | 22.06 | 12.52 | 12.71 |
| Category Avg | -0.11 | -0.7 | 0.11 | -0.66 | 8.77 | 14.61 | 11.79 | 12 |
| Category Best | 2.61 | 10.8 | 14.9 | 27.32 | 94.43 | 43.06 | 29.98 | 130.78 |
| Category Worst | -4.16 | -15.08 | -17.09 | -29.16 | -23.48 | -1.51 | 0.99 | -22.16 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 21.30 | 1855608 | 345.60 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.03 | 222719 | 146.52 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 8.94 | 1068239 | 144.97 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 8.91 | 986076 | 144.49 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 6.38 | 681832 | 103.46 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.35 | 425578 | 102.94 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 5.24 | 183899 | 84.96 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.72 | 485084 | 76.58 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.59 | 263867 | 58.16 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.52 | 102536 | 57.11 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.22 | 1250269 | 52.29 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.11 | 198402 | 50.50 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 3.01 | 438442 | 48.78 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.55 | 243441 | 41.40 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.15 | 139643 | 34.84 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.03 | 143450 | 32.93 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.73 | 144709 | 28.09 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.56 | 73813 | 25.26 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.43 | 9128 | 23.22 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.13 | 1089982 | 18.32 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,67,506.41
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
